09939.HK
Kintor Pharmaceutical Limited
HKSE · Healthcare · Biotechnology · CN
HKD 1.82
−3.96%Margins
Gross margin
16.9%
EBITDA margin
-310.8%
EBIT margin
-432.9%
Net margin
-404.9%
FCF margin
-303.5%
-331.6%
Return on equity
-113.6%
Return on assets
-159.5%
Return on invested capital
0.27x
Asset turnover
-HKD 372.3M
Cash from operations
HKD 0.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026